International Journal For Multidisciplinary Research
E-ISSN: 2582-2160
•
Impact Factor: 9.24
A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal
Home
Research Paper
Submit Research Paper
Publication Guidelines
Publication Charges
Upload Documents
Track Status / Pay Fees / Download Publication Certi.
Editors & Reviewers
View All
Join as a Reviewer
Get Membership Certificate
Current Issue
Publication Archive
Conference
Publishing Conf. with IJFMR
Upcoming Conference(s) ↓
Conferences Published ↓
IC-AIRCM-T3-2026
SPHERE-2025
AIMAR-2025
SVGASCA-2025
ICCE-2025
Chinai-2023
PIPRDA-2023
ICMRS'23
Contact Us
Plagiarism is checked by the leading plagiarism checker
Call for Paper
Volume 8 Issue 2
March-April 2026
Indexing Partners
Competition and Market Exposure of Panax Ginseng Based Medical Products in India: A Case Study on Bangalore Ginseng Market and its Competitive Stand with Ashwagandha Medical Products
| Author(s) | Bipul Jha |
|---|---|
| Country | India |
| Abstract | This research has explored the competition and market share of medical and nutraceutical products containing Panax ginseng in India focusing on Bangalore as a case and comparing them with the leading ashwagandha-derived products. The evaluation is done through secondary research from market reports, FSSAI guidelines, clinical studies, and retail data from Bangalore, the study delineates regulatory structures, market sizes, product positioning, and urban sales trends. In 2024, the ashwagandha market is going to be considerable with a worth of USD 62.6 million. During the period, it is going to have a CAGR of 10.1% through 2033 thanks to its Ayurvedic credibility, local farming, and a wide variety of forms including powders, capsules, and drinks. Panax ginseng, on the other hand, is a low-awareness product positioned in the high-end market, imported, and marketed for vitality and performance, with the tech folks’ wellness scene of Bangalore slowly recognizing it through e-commerce and retail spots dealing with wellness products. The retail sampling conducted in five different locations of Bangalore has revealed that besides ginseng being only found in mixed formulations, ashwagandha is still the most common in pharmacies and Ayurveda shops. This indicates that even though there is competition between the two herbs, it is more through complementarity rather than substitution. Regulatory differences between Ayurveda Aahara and nutraceutical standards give ashwagandha an advantage; however, ginseng strengthens its position by going through premiumization and direct-to-consumer channels. The outcomes emphasize ashwagandha's supremacy while additionally suggesting potential areas for Panax ginseng in the urban Indian market. |
| Keywords | Panax Ginseng, FSSAI Guidelines, CAGR, Ashwagandha, Indian Ginseng, Ayurveda Aahara, Panax Ginseng, ETC. |
| Field | Medical / Pharmacy |
| Published In | Volume 7, Issue 6, November-December 2025 |
| Published On | 2025-12-22 |
| DOI | https://doi.org/10.36948/ijfmr.2025.v07i06.64266 |
Share this

E-ISSN 2582-2160
CrossRef DOI is assigned to each research paper published in our journal.
IJFMR DOI prefix is
10.36948/ijfmr
Downloads
All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.
Powered by Sky Research Publication and Journals